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Abstract
Relatively few Catholic couples in the United States use modern meth-
ods of natural family planning (NFP). So too, few Catholic physicians 
and health professionals prescribe the use of NFP methods for their pa-
tients. Reasons for low use of NFP methods include their perceived low 
efficacy; the complexity of learning, using, and teaching these methods; 
and the prolonged (and often unnecessary) required abstinence. Newer 
and simplified methods of NFP have been developed by physicians and 
scientists that are less complex and use modern technologies of detect-
ing fertility and communicating instructions. Catholic physicians and 
scientists need to continue to answer the call by the Holy Fathers (from 
Pius XII to Benedict XVI) to develop secure and scientifically sound 
methods of NFP.
Prelude
This past semester the research active faculty of the Marquette Uni-
versity College of Nursing met together to present their research ideas for 
writing federal research grants. The gathering was called by the interim dean 
who is a National Institute of Health (NIH)-level researcher and reviewer. 
When I presented my research idea for conducting a comparative study of 
natural family planning (NFP) methods, she (the dean) quickly dismissed 
the idea and said, “Richard, that topic will not fly. The term NFP will be a 
big turn off to the reviewers. You will never get that funded.” Other faculty 
 Paper presented at the 76th Annual Conference of the Catholic Medical Associa-
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members agreed. Although her response was a disappointment for me, I ap-
preciated her honesty. I did not want to waste time writing a federal grant 
proposal with no hope of acceptance. This experience highlighted for me 
the sad state of NFP in this country and the low opinion of it held by health 
professionals.
Introduction
For the past twenty-three years, I have been involved with NFP at Mar-
quette University, a Catholic Jesuit university—providing NFP services, 
researching NFP methods, and educating health professionals on how to 
provide NFP services. I have been writing and editing Current Medical Re-
search in NFP for the United States Conference of Catholic Bishops for the 
past ten years. My experience in providing NFP services, training health pro-
fessionals, and writing about and conducting research in NFP has provided 
me with a unique perspective that I would like to share. However, before I 
do so, I would like to relate some of my concerns about the state of NFP in 
the United States. I share these concerns at a professional and personal level 
because each unintended pregnancy that I (and our professional NFP staff 
at Marquette) encounter affects me and makes me wonder whether we are 
providing the best NFP methods we can, and at the same time, upholding the 
dignity of the women and couples we serve.
Let me begin by noting an increase in the number of unintended preg-
nancies that have occurred over the past twenty-three years through the 
Marquette University NFP programs. At first, I attributed the increase in 
unintended pregnancies to anecdotal evidence and not reflective of our en-
tire program. However, as the number of unintended pregnancies increased, 
I became more uncomfortable. I sympathized with the couples who were 
following the methods consistently and yet were experiencing unintended 
pregnancies even when they had serious reasons not to. As the director of 
a university-based NFP program, I knew I had an obligation to conduct re-
search on the efficacy of the NFP methods that we provide.
Secondly, I recently conducted a review of our NFP couples’ charting 
records and was dismayed at the amount of confusion and prolonged absti-
nence that they often had to experience. I asked myself if this confusion is 
necessary, and what is such prolonged abstinence doing to the couples’ rela-
tionships. I also reflected on the struggle that our health professionals have 
in making sense of these charts.
Thirdly, providing NFP services is complex, time consuming, and ex-
pensive. The training of health professionals to provide NFP services is also 
time consuming and expensive. Many NFP providers experience burn out 
providing the often intense NFP services. In the past twenty-three years, we 
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have lost eight out of the fourteen health professionals who were trained for 
our NFP staff at Marquette. The NFP methods we have been using are inef-
ficient, and it often takes months to properly teach couples to the point that 
they are confident in their use. Finally, we have seen few changes in NFP 
in the past 30–50 years. What we call the “modern” methods of NFP were 
developed in the 1950s and 60s—40–50 years ago.
Based on the 2002 National Survey of Family Growth—a survey of the 
U.S. National Health Statistics division of the CDC—there are only 124,000 
women in their reproductive years that use modern methods of NFP, i.e., 
temperature- or cervical mucus-based methods. That represents only 0.2 per-
cent of all U.S. women and 0.4 percent of all U.S. Catholic women between 
the ages of 15–44.1 We also know (based on a recent, peer-review synthesis 
of the best efficacy studies) that NFP methods have been judged somewhat 
ineffective in helping couples avoid pregnancy.2 This synthesis study will 
have an impact on health professionals, most likely decreasing prescribing 
of these methods by health professionals and re-confirming the impression 
that they are not effective. Finally, based on two recent studies, we know 
that women prefer to have family-planning methods that are effective, easy 
to use, and convenient.3
It is my thesis that there are three major reasons why so few couples 
use NFP methods: 1) NFP methods are relatively ineffective—average or 
typical use will provide an approximately 20–25 unintended pregnancies per 
100 women over a 12 month time period; 2) NFP methods are not all that 
easy to provide or to use; and 3) health professionals are reluctant to provide 
NFP services due to their inefficiency and poor efficacy. Only about 6–10 
percent of physicians in the U.S. and Europe would consider prescribing 
them for birth-control purposes.4
The late Pope John Paul II in the encyclical The Gospel of Life men-
tioned that one of the best means of building a culture of life is to have cen-
ters for natural birth regulation. He also said that health professionals and in 
particular Catholic health professionals and universities need to be involved 
in the provision of these services. But he also stressed the need to provide 
an honest appraisal of their efficacy. In the remainder of this paper, I hope 
to provide an honest appraisal of NFP, and in doing so, to 1) analyze some 
evidence for the inefficiency in current NFP methods, 2) describe perfect-
use and typical-use efficacy of new NFP methods, and 3) discuss efforts to 
increase the efficiency and efficacy in the provision of NFP services. I will 
then conclude with a call for greater participation in the use of NFP meth-
ods by Catholic physicians and health-care professionals and echo a call 
for further research in helping to make these methods more efficient and 
effective.
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Efficiency and Accuracy
of Natural Biological Markers of Fertility
To begin, let me first briefly describe what I mean by Natural Family 
Planning (NFP) and describe the natural biological markers used in NFP to 
estimate the fertile time of the menstrual cycle. This will provide the founda-
tion for further discussion.
NFP is simply the ability to estimate the fertile time in the menstru-
al cycle by the self-observation of natural biological markers of fertility. 
With information about fertility, a couple can decide to avoid or achieve a 
pregnancy through periodic abstinence (to avoid) or focused intercourse (to 
achieve) during the fertile time.
We now know that a man and woman together are fertile only for six 
days in the menstrual cycle. These six days are known as the fertile window. 
They were confirmed by Wilcox and others in a classic study reported in 
a 1995 article in The New England Journal of Medicine.5 The six days are 
based on the physiological knowledge that a human female egg is viable and 
capable of being fertilized only 12–24 hours after ovulation and that sperm 
will survive only 3–5 days in a cervical mucus enriched environment. NFP 
involves using natural biological markers to estimate the beginning, peak, 
and end of that fertile window.
The most common natural biological markers that women use to self-
identify or estimate the fertile window in current systems of NFP include 
calendar-based formulas (determined by statistical estimates of when the 
fertile window will occur within the menstrual cycle), a rise in the woman’s 
basal body temperature (BBT) as a result of the progesterone-stimulated 
upward shift in body temperature after ovulation, the changes in cervical 
mucus and the cervix due to the influence of rising levels of estrogen from a 
ripening egg, and self-measured threshold levels of estrogen and lutuenizing 
hormone (LH) in the urine.
As a human egg ripens in a follicle, the follicle-oocyte complex se-
cretes increasing levels of the female hormone estrogen. The rising levels of 
estrogen stimulate cells lining the cervical canal to produce mucus. Women 
can sense and observe this mucus externally, which indicates the beginning 
of the fertile phase. When the follicle-egg complex reaches the final stage of 
development and is at its largest diameter, it is producing the highest amount 
of estrogen. At this time the special cells in the cervix produce mucus that is 
very watery, clear, profuse, stretchy, and slippery. This type of mucus is very 
obvious to a woman, and it indicates to her a peak in fertility. At the time 
of ovulation (when the egg is released from the ovary), the follicle becomes 
luteinized and produces the female hormone progesterone. The rising levels 
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of progesterone increase the temperature of the human female body about 
one degree Fahrenheit producing a temperature shift that can be measured. 
Progesterone also dries up cervical mucus and forms a plug in the cervix 
so that sperm and bacteria cannot enter the uterus. The drying of the cervi-
cal mucus can also be observed and felt. Consequently, if a woman tracks 
cervical mucus changes and/or basal body temperature, she has markers to 
estimate the beginning, peak, and end of the fertile phase.
One of the hormones that stimulates the release of the egg is LH, which 
surges or peaks about twenty-four hours before ovulation; and, as mentioned 
above, the rising level of the hormone estrogen signals the beginning of the 
fertile phase. If a woman can self-measure the rising level of estrogen and 
the LH surge, she will have a good hormonal estimate of the fertile phase. 
Hormonal fertility monitors are now available for women to self-monitor 
these two reproductive hormones. However, of concern is the accuracy and 
ease of use of observing and interpreting these markers (i.e., temperature, 
cervical mucus, estrogen, and LH) to estimate fertility.
At the Marquette University Institute for NFP, we use and teach all the 
common, natural biological markers of fertility, particularly cervical mucus 
observations and hormonal monitoring of a urinary metabolite of estrogen 
(E3G) and LH with an electronic, hormonal fertility monitor—called the 
ClearBlue Easy Fertility Monitor (CEFM; Inverness Medical Innovations). 
This monitor is a small handheld device designed to measure threshold lev-
els of estrogen and LH in the urine (with a dip stick) and to provide the user 
with three levels of fertility: low, high, and peak.
Figure 1 shows the early charting systems that our couples employ to 
record and rate their cervical mucus observations on a scale of 1 to 8 and to 
record the results from the electronic, hormonal fertility monitor. The rating 
of 1 means no mucus observed and a sensation of dryness. The highest rating 
of 8 indicates that the cervical mucus is at its peak and the woman is at peak 
fertility. Note in the sample chart that the mucus ratings show a gradual rise, 
then a peak (when the mucus is watery, clear, slippery, and profuse), and 
then a sharp drop off. On the bottom of the chart you can see the markings of 
the results from the electronic, hormonal fertility monitor. By charting both 
natural indicators of fertility, there are two markers for the beginning, peak, 
and end of the fertile phase. The two markers also allow for a comparison.
The Marquette University Institute for NFP currently has accumulated 
a thousand fertility charts with both the cervical mucus and hormonal indica-
tors. These charts enabled us to compare both in determining and estimating 
the fertile window. We (Fehring, M. Schneider, and K. Raviele) published 
a study with 60 women and 365 menstrual cycles of data comparing both 
markers in estimating the fertile window.6 We used this data to compare the 
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beginning, peak, end, and length of the fertile window. I have updated the 
results of that study with 160 women participants and 1,279 cycles of data. 
For this present paper, I will remark only on the length of the fertile phase 
of the menstrual cycle.
The length of the fertile phase of the menstrual cycle indicated by cer-
vical mucus (i.e., cervical mucus rated 5–8 on the 1-to-8 scale) was on av-
erage 11.1 days; and with the CEFM, 6.1 days. Clearly using the cervical 
mucus method over estimates the actual fertile phase by 5–6 days, and that 
is a very conservative estimate. This evidence has been confirmed by Ital-
ian researchers who discovered that the fertile phase as estimated by cervi-
cal mucus is approximately seventeen days in length.7 Furthermore, when 
master teachers of the NFP retrospectively estimated the days of fertility on 
cervical mucus-only charts, the correlation between the ratings of the master 
teachers was only 60 percent. Yet, we expect women to prospectively esti-
mate fertility with the same markers. Perhaps cervical-mucus monitoring is 
not as easy and maybe not as accurate as we had assumed.
Another problem revealed in our study was that the cervical-mucus 
peak was missing in 16 percent of the 1,265 cycles of data, and the LH peak 
was missing in about 8 percent of the cycles. Missing indicators for the peak 
of fertility will result in confusion and frustration for the user, since there is 
no indication for the end of the fertile phase.
Three fairly recent studies have compared self-determined biological 
markers of fertility with the gold standard of measuring the day of ovulation, 
the use of serial ultrasound visualization of the developing dominant follicle 
and eventual collapse.8 A study by researchers at the University of Münster, 
Germany, compared the ultrasound-determined day of ovulation with the 
peak or LH days of the electronic, hormonal fertility monitor and found that 
91 percent of the time ovulation occurred during the first peak day, and 97 
percent of the time ovulation occurred during the two days of peak and the 
following high day that are provided by the monitor.9 Another study with 
ultrasound was conducted by an Italian research group at the University of 
Naples (Italy). They found that the Clearblue LH test was 100 percent cor-
related with the ultrasound day of ovulation, the cervical mucus peak was 48 
percent, and the temperature shift showed only a 30 percent correlation with 
the ultrasound-determined day of ovulation.10 Finally, a study from research-
ers in the Netherlands determined the length of the fertile window by use of 
sperm mucus interaction and ultrasound tracking of the follicle and found 
that the most frequent length was three days.11 I recently repeated this study 
by using the estrogen-rise threshold (as determined by the CEFM) and then 
comparing the length of the fertile window with the beginning of mucus. I 
found similar patterns of the estrogen-threshold estimated length with those 
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in the Netherlands study, but the beginning of mucus clearly over-estimated 
the fertile phase.12
We recently compared the number of fertile days as determined by 
mucus observations with the fertile days indicated by use of the CEFM 
among women who were breastfeeding and not ovulating.13 The amount of 
fertile days (i.e., days of abstinence) with use of the fertility monitor was 17 
percent of the total, whereas, the cervical-mucus observations indicated ap-
proximately 50 percent of the total days as fertile. Anecdotally, we hear that 
women often find it frustrating to track mucus for days on end and not have 
a clear picture of their fertility.
In summary, all of the current indicators of fertility utilized in methods 
of NFP are imperfect. All of them produce information in menstrual cycles 
that is hard to interpret. Most of these indicators overestimate the actual 
fertile phase. However, new technology that allows a woman to measure the 
reproductive hormones (rather than a bodily response to them) and that pro-
vides an objective reading is a breakthrough for women with serious reasons 
to avoid pregnancy who wish to use NFP methods.
Efficacy of NFP Methods
When reporting the efficacy of methods of family planning to avoid 
pregnancy, two numbers are provided to indicate the efficacy: the correct-use 
efficacy and the total-use efficacy. The correct-use (also referred to as per-
fect-use) unintended-pregnancy rate refers to those pregnancies that occur 
when the method is used consistently and according to instructions. The to-
tal pregnancy rate includes the combination of both unintended pregnancies 
when the methods are followed correctly and the unintended pregnancies 
that occur when users of the method do not always follow the instructions 
of the method correctly and consistently. Typical-use rates are also used and 
refer to the average rate in the use of the method outside of a controlled ef-
ficacy study. Typical-use and total-use pregnancy rates are sometimes used 
interchangeably in the literature.
Table 1 provides the correct (perfect) and typical (total) use unintended-
pregnancy rates of various contraceptive methods in comparison to NFP meth-
ods. The rates are reported as the percentage of unintended pregnancies per 100 
women over 12 months of use. Table 1 was developed from the information 
provided by James Trussell from Princeton University, an expert in contracep-
tive efficacy.14 These rates are the ones most often cited in medical and nursing 
textbooks and in articles on contraception. As you can see NFP methods have 
a very low perfect-use unintended-pregnancy rate of 1–3 percent, but fairly 
high (i.e., 20–25 percent) typical-use unintended-pregnancy rate, a rate that is 
higher than condom use which is also a behavioral method.
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It should be noted that, the correct-use and typical-use unintended-
pregnancy rates of NFP methods can be deceiving. For example, the more 
days that a particular method indicates are fertile in a menstrual cycle, the 
more likely that that method will have a high perfect-use rate. I like to give 
the example of the mythical “Fehring method” of NFP that indicates that 
the only days of infertility are the first and last days of the menstrual cycle. 
This method will have a very low (next to nothing) unintended-pregnancy 
rate with perfect use, i.e., avoiding having intercourse on all but the first 
and last days of the menstrual cycle. However, it will be difficult for the 
general population to use because it has an average of twenty-six days of 
fertility. Because of the difficulty in using such a method, there will be high 
incorrect-use and total-pregnancy rates. Few couples would want to avoid 
intercourse an average of twenty-six days per menstrual cycle and have only 
two days available for intercourse. A similar situation occurs with the cur-
rent methods of NFP. For example, with the cervical mucus-only methods 
of NFP, 50–60 percent (on average) of the menstrual cycle is considered 
fertile. It will be difficult to achieve an unintended pregnancy with perfect 
use of these methods. However, because these methods are somewhat diffi-
cult to use (i.e., the instructions and the interpretation of the cervical-mucus 
Table 1
Unintended Pregnancy Rate During First Year of Perfect (Correct) and 
Typical Use of Family Planning Method
_________________________________________________________
% Women Experiencing Unintended Pregnancy
Method     Perfect use   Typical Use
_________________________________________________________
Chance           85.0         85.0
Spermicides          18.0         29.0
Withdrawal                                4.0         27.0
Ovulation Method             3.0          25.0
Condoms             2.0         15.0
Pill             0.3           8.0
IUD             0.6           0.8
_________________________________________________________
 Adapted from: J. Trussell, “Contraceptive Failure in the United States,” Contraception 
70 (2004): 89–96.
 Typical-use rates are based on the analysis of the data from the 1995 National Survey 
for Family Growth by Trussell and the reanalysis of the World Health Organization five-
country study of the ovulation method. See J. Trussell and L. Grtummer-Strawn, “Con-
traceptive Failure of the Ovulation Method of Periodic Abstinence,” Family Planning 
Perspectives 22 (1990): 65–75.
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signs are not always easy, and there are many days of “estimated” fertility), 
the typical-use unintended-pregnancy rate will be high. On the other hand, 
more accurate methods with shorter estimated fertile phases, might have 
higher perfect-use rates but lower typical-use unintended-pregnancy rates, 
especially if the methods are easy to understand and use.
In table 2, I have included the perfect-use and typical-use rates of the 
most recent NFP efficacy studies that have been published in peer-reviewed 
journals, in addition to a large classic (five-country study) of the ovulation 
method conducted by the World Health Organization (WHO).15 The WHO 
study analyzed the efficacy of the cervical mucus-only ovulation method,16 
the Howard et al. study evaluated a standardized type of cervical mucus-only 
method,17 the first Arevalo et al. study evaluated the efficacy of a fixed-day 
calendar-based method,18 the second Arevalo et al. study determined the ef-
ficacy of a simplified cervical mucus-only study,19 the Frank-Herrmann et 
al. study analyzed the efficacy of a European temperature-plus-cervical-mu-
cus-plus-calendar formula,20 the first Fehring et al. study determined the ef-
ficacy of a combination of cervical mucus plus the CEFM,21 and the second 
Fehring et al. study determined the retrospective efficacy of a combination 
Table 2
Classic and Recent NFP Efficacy Studies: Correct-Use and Typical-Use 
Unintended-Pregnancy Rates per 100 Women Over 12 Months of Use
_________________________________________________________
Study                 Indicators      Length    Correct     Typical
_________________________________________________________
WHO28
(Billings)                           Mucus      (25–32)         3.0 22.0
Howard et al.29
(Creighton)              Mucus      (25–32)         0.1 17.0
Arevalo et al.30
(SDM)                             Fixed Calendar   (26–32)         5.0 12.0
Arevalo et al.31
(TwoDay)              Mucus      (13–42)         4.0 14.0
Frank-Herrmann et al.32
(STM)                               Mucus/Temp     (25–35)         0.6             1.8
Fehring et al.33      Mucus/E3G/LH   (21–42)         2.0 13.0
Fehring et al.34
(Marquette)       Mucus/Temp/LH  (21–42)        1.0 11.0
_________________________________________________________
 Range of length of menstrual cycles in study.
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of either cervical-mucus observations, basal body temperature, and/or the 
use of the CEFM.22 I would like to point out that these studies included 
only women with regular menstrual-cycle lengths. The Arevalo et al. study 
and the two Fehring et al. studies having the most liberal length of 13–42 
days.23 The typical-use unintended-pregnancy rate of the WHO study of 22 
percent is the highest.24 The Frank-Herrmann et al. European double-check 
method has the lowest typical-use rate, similar to that found with oral hor-
monal contraceptives.25
The unintended pregnancy rates jump considerably with use of NFP 
methods when other-than-regular cycles (i.e., including post-pill, post-par-
tum, and peri-menopause) are included in the calculations. For example, in 
the Howard et. al. study, the typical unintended rate of a cervical mucus-only 
method jumps to 24 percent among breastfeeding women,26 and a database 
of the same method from Marquette University indicates that the ovulation-
method rate is approximately 22 percent—similar to the WHO study rate.
We recently conducted a retrospective cohort study comparing the un-
intended-pregnancy rates of two methods, i.e., a cervical mucus-only meth-
od versus a cervical-mucus method with the CEFM as a double check for 
the beginning and end of the fertile phase.27 The participants were essentially 
from the same clinical sites. The correct-use rates were similar between the 
two methods (around 1–3 percent), but the total unintended-pregnancy rates 
(13 percent for the CEFM method vs. 23 percent for the cervical mucus-only 
method) were statistically different (Fisher Exact Test, P < 0.05)—the actual 
number of unintended pregnancies (28 vs. 41) is almost double with the cer-
vical mucus-only method. We believe the use of hormonal monitoring as an 
objective double check for estimating the fertile window will help lower the 
unintended pregnancy rate. However, the evidence is thin. We need random-
ized clinical trials to know with more confidence.
Efficient Methods of NFP
I will now describe some recent efforts to streamline NFP methods that 
are more user- and provider-friendly (and yet maintain efficacy). Before I do 
so, however, let me include a brief historical note. The first person to translate 
the scientific findings of the menstrual cycle and the probable days of fertility 
into a usable natural method of family planning was Leo Latz, a young physi-
cian (obstetrician and gynecologist) from Loyola University and a member 
of the Chicago Guild of the Catholic Medical Association (then known as the 
Federation of Catholic Physicians’ Guilds). In 1932, he developed a simple 
calendar-based method of NFP that could be used in a twelve-minute office 
session by a physician, nurse, or social worker. His method became known as 
“rhythm” since the title of his widely published, small, blue book was “The 
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Rhythm of the Fertile and Infertile Phase of the Woman.” The first few is-
sues of the then-new journal The Linacre Quarterly published articles about 
his method, the controversies surrounding the use of his methods by Catho-
lics and Catholic physicians, and announcements of Dr. Latz presenting his 
method at guild meetings in Chicago and New York.
More recent efforts of simplifying NFP methods have been developed 
by scientists at the Georgetown University Institute for Reproductive Health. 
The Georgetown researchers developed a simple fixed-day method (or what 
they call the standard-days method [SDM]) whereby days 8–19 are always 
considered fertile.35 The method is for women who have menstrual cycles 
between 26–32 days in length. They implemented the method with a simple 
system of colored beads (called Cyclebeads) that indicate the days of fertil-
ity with white beads and the infertile days with brown beads. A three-country 
efficacy study found a correct-use unintended-pregnancy rate of 5 percent 
and a typical-use rate of 12 percent.
Another simple NFP method developed at Georgetown is the TwoDay 
Method.36 This is a simplified version of the cervical mucus-only method. 
It entails asking two questions: 1) did I notice any secretions today? and 2) 
did I notice any secretions yesterday? If the woman answers “No” to each 
question she can consider herself as infertile. They also published an effi-
cacy study of this method among couples from three countries and found a 
typical-use rate of 14 percent.
European physicians and scientists took on the task of creating an ef-
ficient and accurate method of NFP for busy European women who wanted 
a secure, natural method of birth control.37 They studied the various mark-
ers and rules of current methods and developed what they call the double-
check method of NFP, i.e., a double-check sympto-thermal method. The 
double check for the beginning of the fertile phase is the presence of cer-
vical mucus and/or a calendar-based formula; the end of the fertile phase 
is the peak in cervical mucus or the BBT temperature shift (whichever 
comes last). As mentioned, a recent prospective efficacy study among 900 
couples provided efficacy rates for this method that rival the hormonal 
birth-control pill.
At Marquette University we developed what we call the Marquette 
Light method of NFP that can be taught initially in a twelve-minute office 
session. The method uses either cervical mucus or the CEFM and a calen-
dar-based formula as a double check for the beginning and end of the fertile 
phase. Whether the woman-user observes cervical mucus or uses the CEFM, 
she rates her fertility as being low, high, or peak, and she utilizes the same 
fertility calendar-based formula for a double check. This simplified method 
is currently being evaluated for its efficacy.
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Besides simplifying the use and provision of NFP methods, there have 
been efforts to integrate information technology into the use and provision of 
NFP services, particularly the use of the internet. In the United States, there 
are a number of Web-based programs that provide information on how to use 
NFP methods. These include the Northwest Family Services which teaches a 
multiple fertility-indicator method (i.e., cervical mucus and basal body tem-
perature), the Franciscan-system cervical-mucus method being developed 
by a physician and nurse practitioner team in California, and the Ovusoft 
system developed by Toni Weschler, the author of the book “Taking Charge 
of Your Fertility.”38 The Ovusoft system is the most widely used software 
system for tracking fertility. It is also used as an online charting system.
At Marquette University we recently received a grant from the Our 
Sunday Visitor Institute to develop an online system to teach couples to use 
NFP. Over the past five years we have discovered that couples are often re-
luctant (or too busy) to come to an onsite setting for in-person NFP services 
and often do not show up for appointments. Furthermore, we receive e-mail 
requests to learn NFP over the e-mail system on a weekly basis. An online 
service system for NFP is efficient in being able to reach people around the 
world without leaving their homes or places of work.
The Marquette online NFP services are in development. We currently 
have a Web portal site, http://nfp.marquette.edu, and have begun to pilot 
the online program with fifty couples. The Web site has free information on 
NFP, downloadable charting systems, access to protocols for special circum-
stances (e.g., using NFP while breastfeeding), and instructions for achieving 
and avoiding pregnancy. A unique aspect of the information section of the 
Web site is a one-page, simple Quick Start Instructions that can be read in 
five minutes and allows the user to begin charting and using NFP.
Couples who register on the Web site are able to access our electronic 
charting system, the discussion forums, and have consultation from profes-
sional nurse NFP teachers, an NFP-only physician, and a Catholic moral 
theologian. The charting system also notifies the user of possible health 
problems, including unusual bleeding, infertility, and cycle dynamics that 
are out of the norm. However, none of these systems has been studied for its 
efficacy and ease of use; furthermore, the efficacy of these systems will only 
be as good as the NFP method that they provide.
Conclusion
In conclusion, I recommend and implore physicians, nurses, and sci-
entists (particularly Catholic physicians, nurses, and scientists) to continue 
to develop secure, accurate, and easy-to-use and -access methods of NFP. 
We desperately need to have good randomized clinical trials comparing 
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methods of NFP so that we can, with confidence and honesty, tell couples 
which methods are the most effective. We also need research in more ac-
curate means to estimate the fertile phase of the menstrual cycle, and in 
particular the beginning of the fertile phase. So too, we need to have better 
ways of helping women and couples to monitor fertility during special cir-
cumstances, such as during breastfeeding and the peri-menopause (these are 
especially fearful times for women and couples who have serious reasons 
not to have an unintended pregnancy). We need to include the new informa-
tion technology (Internet, pod casting, YouTube, cell phones, etc.) in the 
provision of NFP services to make them easier to use, easier to access, and 
more attractive to young couples. Finally, we need to have NFP methods that 
are practical for physicians and other health professionals to provide in their 
everyday practices.
Ever since Pope Pius XII in 1951 implored professional nurses to pro-
vide a secure method of NFP to couples, the Catholic Church has been en-
couraging Catholic health professionals to study and provide effective meth-
ods of NFP. Pius XII asked Catholic scientists to “bend their backs” to help 
with developing secure natural methods. Pope Paul VI said it is the “proper 
professional duty” for Catholic health professionals to provide secure NFP 
methods, and that scientific research on this topic needs to be intensified. 
Pope John Paul II was supportive of NFP and pleaded with Catholic profes-
sional nurses, physicians, and scientists to continue their efforts in develop-
ing effective methods of NFP.
As we proceed into the future my challenge to you (as Catholic phy-
sicians) is to conduct good and honest efficacy studies and, in particular, 
randomized clinical trials of NFP methods. We need to have Catholic physi-
cians and nurses properly trained in how to teach these methods (should that 
not be part of the mission of a Catholic medical or nursing school?) Finally, 
we need Catholic physicians and professional nurses (especially advanced-
practice nurses) confidently to integrate NFP methods into their practice.
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